Modulation of the epidermal growth facto
β
Pamela A. Maher
π
Article
π
1993
π
John Wiley and Sons
π
English
β 883 KB
Institute for Diabetes and Endocrinology, La lolla, California 92(1.?7 Treatment of Swiss 3T3 fibroblasts with basic fibroblast growth factor (bFGF) lead to a rapid reduction in epidermal growth factor (EGF) binding and a slower inhibition of EGF receptor autophosphorylation. The reduction in bindi